0001811339-20-000002.txt : 20200507 0001811339-20-000002.hdr.sgml : 20200507 20200507170624 ACCESSION NUMBER: 0001811339-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200507 DATE AS OF CHANGE: 20200507 EFFECTIVENESS DATE: 20200507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Paragon Biosciences Evozyne Capital, LLC CENTRAL INDEX KEY: 0001811339 IRS NUMBER: 844550055 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-366520 FILM NUMBER: 20857496 BUSINESS ADDRESS: STREET 1: 330 N. WABASH AVENUE STREET 2: SUITE 3500 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: 312-847-1322 MAIL ADDRESS: STREET 1: 330 N. WABASH AVENUE STREET 2: SUITE 3500 CITY: CHICAGO STATE: IL ZIP: 60611 FORMER COMPANY: FORMER CONFORMED NAME: Paragon Biosciences Evozyne Capital LLC DATE OF NAME CHANGE: 20200505 D 1 primary_doc.xml X0708 D LIVE 0001811339 Paragon Biosciences Evozyne Capital, LLC 330 N. WABASH AVENUE SUITE 3500 CHICAGO IL ILLINOIS 60611 312-847-1322 DELAWARE Paragon Biosciences Evozyne Capital LLC Limited Liability Company true 2020 Patrick J. Morris 330 N. Wabash Avenue Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer Director Manager, President, Executive Vice President, Legal Affairs and General Counsel Darien Parhad 330 N. Wabash Avenue Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer Treasurer Biotechnology Decline to Disclose 06b false 2020-04-27 false true false 0 9473684 9473684 0 The offering is closed. Includes determination of value of certain assets contributed to the Company by an investor. false 2 0 0 0 false Paragon Biosciences Evozyne Capital, LLC /s/ PATRICK J. MORRIS Patrick J. Morris President 2020-05-06